微创脊椎器材产品线 - 发展阶段、细分市场、地区和国家、监管途径、主要参与者（2024 年版）

该报告提供了有关微创脊椎器械产品线的全面信息，包括处于不同开发阶段的产品的比较分析以及正在进行的临床试验的数据。

目录

第1章 目录

第2章简介

第3章 开发中产品

• 微创脊椎器材 - 管道产品：依开发阶段划分
• 微创脊椎器材 - 管道产品：按细分市场
• 微创脊椎器材 - 管道产品：依地区
• 微创脊椎器材 - 管道产品：依监管途径
• 微创脊椎装置 - 管道产品：依预计核准日期
• 微创脊椎装置 - 正在进行的临床试验

第4章 微创脊椎器材－各公司在研产品

• 微创脊椎器材公司 - 管道产品：依开发阶段划分
• 微创脊椎器材 - 管道产品：依开发阶段划分

第5章 微创脊椎器材公司及产品概述

第6章 微创脊椎装置 - 最新进展

• 2024 年 10 月 8 日：SpineGuard 获得空心 PsiFGuard 的 510(K) 批准
• 2024 年 9 月 30 日：SpineGuard 获得 FDA 批准商业发布 PsiFGuard，这是一种专用于骶髂关节固定的新型智慧钻孔设备
• 2024 年 7 月 10 日：Aurora Spine Corporation 出席Sixth Annual American Society of Pain & Neuroscience Conference
• 2024 年 7 月 4 日：SurGenTec 获得Ion Facet Screw System的额外 510(K) 许可
• 2024 年 5 月 30 日：与关键意见领袖合作，成功培训
• 2024 年 3 月 12 日：改良的 MAGEC X 系统用于早发性脊椎侧弯治疗，现已在英国上市
• 2024 年 2 月 15 日：SurGenTec 获得Ion Facet Screw System的额外 510(K) 许可
• 2023 年 12 月 12 日：ZimVie 宣布Vital Spinal Fixation System与Brainlab Spine & Trauma Navigation相容
• 2023 年 11 月 13 日：Aurora Spine 安排电话会议以更新投资者资讯并报告 2023 年第三季业绩

第7章附录

GlobalData's Medical Devices sector report, "Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Minimally Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Minimally Invasive Spinal Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Minimally Invasive Spinal Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Minimally Invasive Spinal Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Minimally Invasive Spinal Devices Overview

3 Products under Development

• 3.1 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• 3.2 Minimally Invasive Spinal Devices - Pipeline Products by Segment
• 3.3 Minimally Invasive Spinal Devices - Pipeline Products by Territory
• 3.4 Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• 3.5 Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• 3.6 Minimally Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimally Invasive Spinal Devices - Pipeline Products under Development by Companies

• 4.1 Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• 4.2 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimally Invasive Spinal Devices Companies and Product Overview

6 Minimally Invasive Spinal Devices- Recent Developments

• 6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
• 6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
• 6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
• 6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
• 6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
• 6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
• 6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
• 6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
• 6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials
• Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials